John C. Rotschafer

Therapeutic monitoring of vancomycin for serious methicillin-resistant <i>Staphylococcus aureus</i> infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Michael J. Rybak, Jennifer Lê, Thomas P. Lodise et al. · American Journal of Health-System Pharmacy · 2020 · 1K citations · Full text

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Michael J. Rybak, Jennifer Lê, Thomas P. Lodise et al. · Clinical Infectious Diseases · 2020 · 391 citations · Full text

Vancomycin pharmacokinetics in patients with various degrees of renal function

Keith A. Rodvold, Robert A. Blum, Judith Fischer et al. · Antimicrobial Agents and Chemotherapy · 1988 · 241 citations

Intravenous Vancomycin, Urology, Steady State +12

Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations

John C. Rotschafer, Kent Crossley, Darwin E. Zaske et al. · Antimicrobial Agents and Chemotherapy · 1982 · 187 citations · Full text

Pharmacotherapy, Antimicrobial Chemotherapy, Drug Resistance +18

Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model

Karl Madaras‐Kelly, Beth E. Ostergaard, Laurie B. Hovde et al. · Antimicrobial Agents and Chemotherapy · 1996 · 156 citations · Full text

Auc/mic Subgroups, Generic Predictor, Antimicrobial Chemotherapy +19